DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 266 | +88.7% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 141 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 141 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 141 | -66.6% | 0.00% | – |
| Q3 2020 | $8,000 | +14.3% | 422 | +9.3% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 386 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 386 | -11.5% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 436 | +9.3% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 399 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 399 | -33.5% | 0.00% | – |
| Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |